A medicine can be approved, effective, and still never reach the people who need it most. If your community is underrepresented in research, the newest treatments can feel out of reach long before they reach a pharmacy. High costs, limited availability, and simple lack of awareness stop many people from ever hearing about the trials where those medicines are tested. Solving that takes more than science. It takes education, trust, and community connections.
The first challenge you may face is financial. Even when participation in a clinical trial is free, the indirect costs like travel, lost workdays, or childcare can be overwhelming. These hidden burdens discourage many, particularly those already struggling with healthcare expenses. Addressing these inequities means going beyond covering trial-related medical costs. More and more programs now include stipends, transportation support, or flexible scheduling to bridge the gap between opportunity and reality. When the money question is settled at the outset, you can focus on treatment rather than survival.
Another obstacle to treatment accessibility lies in awareness. Many of you have felt lost because you just didn’t know where to start. You didn’t know what trials were available to you, or how to access them. This is especially an issue in underserved communities where healthcare resources are already limited. Traditional recruitment campaigns often fail to reach some of you because they rely on narrow networks or doctor referral.
Treatment Accessibility Through Collaboration
Now you may be thinking, “Why are you telling me this? I have already experienced what is wrong with the system.” We recognize the challenges you are facing, and we want to be clear about what trialport does and does not do about them. Our aim is treatment accessibility through understanding: helping you find out that relevant research exists and understand it in plain language, guided by behavioral science and trust-building principles. We do not recruit, screen, or enroll you. Those decisions belong to you and the study team.
Collaboration is vital for dismantling the structural barriers that, in turn, create practical barriers for you. We work with community organizations, advocacy groups, and trusted networks to put trials on your radar. Creating these partnerships does four main things. Communities help shape how trials are communicated, so that messaging is relevant and culturally sensitive. They highlight that accessing next-generation medicines is not only about science, but about fairness and representation in research. They demonstrate that achieving treatment accessibility requires collaboration across multiple fronts so no one is excluded due to language, income, or geography. They then become trusted relationships that create pathways for you to ask questions openly and receive clear, reliable guidance.
Making Trials Visible to Everyone, Fairly
Including diverse populations in research is not just a logistical goal, it is a scientific necessity. Trials that lack diversity produce results that fail to reflect the real-world population. Underrepresented groups are disproportionately affected by this gap, leading to treatments that are less effective or less safe for them. To solve this, awareness has to reach far beyond the usual channels.
Here is how it works on trialport. When you choose to learn more about a study, you get a plain-language summary with medifit™ + readifit™ self-reflection tools. Each asks one question:
- medifit asks: Is this trial right for my health? It invites you to say, in your own words, how closely you believe you match what the study is looking for. It does not determine eligibility. The study team confirms that with you.
- readifit asks: Is this trial right for my life? It invites you to reflect on your confidence in taking part and whether you could realistically stay with the study through its demands. Together, the two questions help you gauge your own readiness before you contact anyone.
We operate before the point of recruitment. Our job is to make you aware of ongoing research and help you understand it, so that you can consider studies that may fit you. We work to make communities aware of trials across all demographics and locations, so opportunities reach far beyond the usual channels. Eligibility is not the same as readiness, and knowing early whether a study could fit your life spares you, and the study team, avoidable cost and disappointment later.
Building Long-Term Trust Through Transparency
Transparency is essential for maintaining your confidence throughout the trial process. When you understand the goals, risks, and expected outcomes of participation, you feel respected as a partner rather than a subject. Clear, jargon-free communication ensures no one is left confused or uncertain. Regular updates, easy-to-read materials, and feedback channels further enhance this sense of partnership. For trialport, transparency is non-negotiable. By remaining accountable to you and your communities, we demonstrate that ethical integrity and research advancement can work hand in hand.
Trust is at the core of this effort. Trials and the way people hear about them need to be designed so that your well-being, not financial gain, drives the invitation to consider a study. Too often, healthcare feels transactional. trialport rejects that approach, focusing instead on integrity and reliability. We remain agnostic, never prioritizing the highest bidder over what benefits you. This commitment to trust creates an environment in which you can feel confident enough to consider participation. We know trust is not built overnight, but through transparency, clear communication, and consistent respect for patient autonomy. We are on a mission to earn your trust.
Measuring Progress by What People Actually Experience
Success cannot be measured solely by the number of people enrolled. It must also reflect your experiences and satisfaction. By collecting feedback, tracking retention, and listening to participants, researchers gain a clearer picture of how trials are serving you. These measures highlight what is working and where improvements are needed in how studies reach and support people, so future trials are more inclusive and effective. For trialport, success is defined by the quality of relationships built, the trust maintained, and the communities served.
When you feel seen and valued, next-generation medicines become more than distant opportunities. They become real options to weigh. Addressing cost, availability, and awareness challenges requires collaboration at every level. If you are weighing a study, see what participation could involve. If you are part of an advocacy group or community organization, see how trialport works with communities.
About the author
Keith Berelowitz has spent more than twenty years watching clinical trials work on paper and struggle in real life. He has helped run studies, advises sponsors and CROs on how they engage with people, and chairs a UK research ethics committee, where consent forms and participant information sheets cross his desk every month. That vantage point led to one conclusion: most trial problems are not failures of science. They are failures of understanding at the moment a person decides.
He founded trialport, a clinical trial navigation and decision-support platform, on the view that finding a study is only the first step. A plain-language summary and the medifit™ + readifit™ self-reflection tools help people judge whether a trial fits their health and their life before they ever contact a site. Understanding comes first. Decisions follow.